Maxim Group Keeps Their Buy Rating on Lineage Therap (LCTX)

TipRanks14:25 ET · Ratings

Lineage Is Maintained at Neutral by Mizuho

Dow JonesJan 8 11:28 ET · Ratings

Mizuho Securities Maintains Lineage(LINE.US) With Hold Rating, Cuts Target Price to $67

Moomoo NewsJan 8 08:34 ET · Ratings

Express News | Lineage Inc : UBS Cuts Target Price to $64 From $75

ReutersJan 6 09:13 ET

D. Boral Capital Maintains Buy on Lineage Cell Therapeutics, Maintains $2 Price Target

BenzingaJan 3 09:07 ET · Ratings

Lineage Cell Therapeutics Analyst Ratings

BenzingaJan 3 09:06 ET · Ratings